Sugammadex n = 21 | Neostigmine n = 20 | ||
---|---|---|---|
Gender | |||
female, n and (%) | 7 (33) | 8 (40) | |
male, n and (%) | 14 (67) | 12 (60) | |
Age (years) | 54.1 ± 9.8 | 54.1 ± 10.4 | |
Weight (kg) | 73.9 ± 14.2 | 73.1 ± 14.7 | |
Height (m) | 1.7 ± 0.1 | 1.7 ± 0.1 | |
BMI (kg/m2) | 25.2 ± 4.2 | 25.3 ± 3.9 | |
Liver disease: | |||
HBV-related cirrhosis ± HCC, n and (%) | 2 (9.5) | 0 (0) | |
HCV-related cirrhosis ± HCC, n and (%) | 9 (42.8) | 6 (30) | |
Alcohol-related cirrhosis ± HCC, n and (%) | 6 (28.5) | 6 (30) | |
Alchohol + HBV-related cirrhosis, n and (%) | 1 (4.7) | 0 (0) | |
Alchohol + HCV-related cirrhosis, n and (%) | 0 (0) | 4 (20) | |
HIV coexists, n and (%) | 2 (9.5) | 2 (9.5) | |
Other disease, n and (%) | 3 (14.2) | 4 (19) | |
Pre-operative liver and renal function | p | ||
MELD | 16.8 ± 7.3 | 21.4 ± 9.1 | 0.1 |
AST (IU/l) | 67.4 ± 39.1 | 122.8 ± 62 | 0.15 |
ALT (IU/l) | 48.6 ± 41.1 | 89.7 ± 168.7 | 0.30 |
LDH pre-op (IU/l) | 485.3 ± 191.5 | 457.8 ± 368.4 | 0.93 |
TBil (mg/dl) | 6.7 ± 10.2 | 11.5 ± 13.4 | 0.45 |
DBil (mg/dl) | 3.8 ± 6.1 | 6.1 ± 8.2 | 0.6 |
GGT (IU/l) | 155 ± 340 | 75 ± 74 | 0.34 |
Albumin (mg/dl) | 29.9 ± 6.2 | 31 ± 6.4 | 0.27 |
ClCr (ml/min) | 86.5 ± 34.9 | 80.7 ± 36.8 | 0.61 |
Postoperative liver and renal function | |||
AST (IU/ml) | 1246 ± 1060 | 1688 ± 1508 | 0.29 |
ALT (IU/m) | 654 ± 348 | 1346 ± 1594 | 0.07 |
LDH (IU/l) | 2986 ± 1699 | 3957 ± 5804 | 0.49 |
TBil (mg/dl) | 4.6 ± 2.5 | 6.9 ± 4.6 | 0.25 |
DBil (mg/dl) | 3.2 ± 2 | 4 ± 3.2 | 0.65 |
GGT (IU/l) | 58 ± 47 | 77 ± 56 | 0.27 |
Albumin (mg/dl) | 19.8 ± 8 | 21.3 ± 6 | 0.82 |
ClCr (ml/min) | 86.2 ± 30.7 | 72.2 ± 29.1 | 0.14 |